Delivery Order SPE2DB22D3501-SPE2DB24FXB69
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a firm fixed price of $1,069.34 awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CAPLYTA 21 MG CAPSULE 30S, with a period of performance through May 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of CAPLYTA 10.5 MG CAPSULE 30S. The contract has a firm fixed price ceiling value of $1,069.11 and a period of performance through February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,134.39, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a medication, to support DLA's medical supply requirements. The contract has an ultimate completion date of June 13, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,836.32 firm-fixed-price contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CAPLYTA 42 MG CAPSULE 30S. The contract has a total ceiling value of $2,504.85 and runs through October 23, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,771.38, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 23, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,895.03 firm fixed-price contract is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has a completion date of July 9, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product CAPLYTA 21 MG CAPSULE 30S. The contract has a ceiling value of $1,253.37 and a performance period through April 10, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,004.95, is a delivery order for the drug CAPLYTA 10.5 MG CAPSULE 30S. It has an ultimate completion date of April 7, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.22, is a delivery order for the provision of CAPLYTA 21 MG CAPSULE 30S. The contract is a firm fixed-price agreement with an ultimate completion date of April 14, 2025. This contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and...